GHK-Cu × ng peptide — lab test, February 2026
freedomdiagnosticstesting.com publishes a public verification portal. Any test attributed to this lab can be looked up and confirmed directly with the lab — so this result doesn't rest on our review alone.
This certificate carries no lookup code.
Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 38.65 mg · Lab measured 38.65 mg
100% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 9.7 mg on both the label figure and the measured one.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
Independent HPLC purity analysis of GHK-Cu from ng peptide, performed by freedomdiagnosticstesting.com on February 27, 2026. Reported purity: 99.091%. Net content: 38.65 mg against 38.65 mg labeled (100% of label). Batch GHPV01. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Other lots of GHK-Cu from ng peptide
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| GHK-12 | 21 Apr 2026 | ILS Laboratories | 99.89% | 105% | Unverified |
| GHK08 | 16 Jan 2026 | Janoshik Labs | 99.693% | 120% | Unverified |
| KLW7198 | 12 Dec 2025 | freedomdiagnosticstesting.com | 99.682% | 62% | Unverified |
| GLW4760 | 12 Dec 2025 | freedomdiagnosticstesting.com | 99.6% | 85% | Unverified |
| GHKC08 | 8 Nov 2025 | freedomdiagnosticstesting.com | 99.926% | 107% | Unverified |
| GHK07 | 10 Sept 2025 | BioRegen | 99.85% | 106% | Unverified |
| AIJKO1 | 12 Jan 2025 | freedomdiagnosticstesting.com | 99.359% | 100% | Unverified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion